General Assemblies

General Assembly and presentations 2011

• Invitation
• Minutes
• The extended Williams’ trend test - Background and practical example (Anders Malmberg)
• Exposure-Response Analysis – Regulatory perspectives (Christoffer W. Tornøe)

General Assembly and presentations 2010

• Invitation
• Minutes
• Discussion on Randomisation and Blinding (Lars Endahl)
• Perspectives on Non-Inferiority Clinical Trials – based on draft FDA guidance doc (Kristian Windfeld)

General Assembly 2009

• Invitation
• Minutes

General Assembly 2008

• Invitation

General Assembly and presentations 2007

• Invitation
• Minutes
• Biostatistics use of TCS in Mumbai (Trine Næstoft Juhl)
• SAS Drug Development

General Assembly and Miniseminar on Data Monitoring Commitees and safety 2006

• Invitation
• Information about the seminar on Data Monitoring Commitees and safety
• Integrated Analyses of Safety - Data needed! (Marie Louise Valentin)
• DMC – how and what should they evaluate? (Bjarne Nielsen)
• Analysis of Safety Data - Is More Enough? (Marc Andersen)

General Assembly and seminar on QT prolongation 2005

• Invitation
• Minutes
• Information about seminar on QT prolongation
• Introduction to QT Prolongation Trials (Thomas Jon Jensen)
• Status on guidelines (Bjarne Nielsen)

General Assembly (extraordinary) 2002

• Invitation